Skip to main content
PepStack
Wiki · Profile

Selank

TP-7 · Selanc

Nootropic & CNSPreclinical
From$1.62/mgCompare prices
MW
751.9g/mol
Formula
C33H57N11O9

Selank is a synthetic peptide analogue of tuftsin, classified as an anxiolytic and neuroactive compound. Researchers primarily study Selank for its potential effects on anxiety regulation and cognitive enhancement. Key findings from recent studies indicate that Selank can modulate brain-derived neurotrophic factor (BDNF) levels, which are crucial for memory and learning, and it has shown promise in improving cognitive function in models of ethanol-induced memory impairment. Additionally, studies suggest that Selank may influence functional connectivity in brain regions associated with anxiety and executive functions. Current research continues to explore its therapeutic applications and mechanisms of action, particularly in the context of anxiety disorders and cognitive decline.

Chemical Profile

Chemical Profile

Chemical structure
Chemical Structure
FormulaC33H57N11O9
Molecular Weight751.9 g/mol
CAS Number129954-34-3
PubChem CID11765600
ChEMBL IDCHEMBL4585920

Half-Life

INIntranasal

~15 minutes

POOral

Poor bioavailability

Intranasal administration is preferred due to rapid absorption and onset of action.

Mechanism

Mechanism of Action

Selank, a peptide analogue of tuftsin, exerts its anxiolytic effects primarily through modulation of the brain-derived neurotrophic factor (BDNF) signaling pathway, enhancing neuroplasticity and cognitive function. It is believed to influence the levels of enkephalins, which are endogenous opioid peptides, thereby affecting the opioid signaling pathway and potentially modulating the PI3K/Akt and MAPK pathways involved in cellular survival and stress response. While the precise mechanisms remain partially understood, Selank's impact on functional connectivity in brain regions associated with anxiety and cognition suggests a multifaceted role in neurochemical regulation.

Research

58 Research Publications

417

Total Citations

8

Human/RCT

1.1

Avg. Influence

2023

Latest

Sort
Filter
#01

Natural and hybrid ("chimeric") stable regulatory glyproline peptides.

Review
37
Researchers observed that glyproline peptides, including Selank, exhibit stability comparable to major pharmacological preparations, allowing for potential oral administration.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#02

Tuftsin - Properties and Analogs.

Siebert Agnieszka, et al. · Current medicinal chemistry · 2017

ReviewInfluence1.0
35
The review summarized the biological activities and clinical potential of tuftsin and its analogs, emphasizing their anti-tumor, anti-inflammatory, and antimicrobial properties.

Key findings

  1. 01The review included 86 documents, highlighting tuftsin's significant biological activities.
  2. 02Thirty-two studies focused on tuftsin's effects in humans, while others explored its analogs' properties.
  3. 03Many tuftsin derivatives demonstrated potential in cancer treatment and as components of vaccines.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#03

Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.

Seibertz Fitzwilliam, et al. · Cardiovascular research · 2023

In VitroInfluence1.0
26
Researchers studied how atrial fibrillation (AF) affects heart cell function using human heart cells created from stem cells. They found that mimicking AF conditions led to significant changes in electrical activity and heart cell behavior, which could help in developing new treatments for AF.

Key findings

  1. 01Researchers observed that electrical pacing mimicking AF conditions caused decreased calcium current and impaired potassium current in heart cells.
  2. 02The study found that long-term pacing resulted in changes such as increased potassium current and altered heart cell contractility.
  3. 03Researchers successfully modeled AF-associated changes in heart cells, providing a new platform for discovering potential antiarrhythmic therapies.
PubMed
#04

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

Volkova Anastasiya, et al. · Frontiers in pharmacology · 2016

Animal
20
The study demonstrated that selank significantly altered the expression of genes involved in GABAergic neurotransmission in the frontal cortex of rats.

Key findings

  1. 01Researchers observed significant changes in the expression of 45 genes one hour after administering Selank or GABA.
  2. 02Three hours post-administration, 22 genes showed altered expression.
  3. 03The study found a positive correlation in gene expression changes between Selank and GABA within the first hour.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#05

Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.

Review
18
Researchers observed that Selank, along with other GABAergic agents, is associated with significant toxicities related to abuse and dependence, highlighting the need for careful evaluation of its abuse potential.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#06

Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.

AnimalInfluence2.0
17
The study demonstrated that Selank and tuftsin peptides positively influenced emotional stress responses in various rodent models.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#07

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.

In Vitro
13
The study demonstrated that Selank acts as a positive allosteric modulator of GABA receptors, potentially contributing to its anxiolytic effects.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#08

The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.

Human
13
The study demonstrated that Selank inhibited enkephalin-degrading enzymes, which may contribute to its efficacy in managing anxiety and phobic disorders.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#09

The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.

Animal
12
Researchers observed that selank and its fragment Gly-Pro significantly altered the expression of inflammation-related genes in mouse spleen, indicating its immunomodulatory potential.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
#10

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

Filatova Elena, et al. · Frontiers in pharmacology · 2017

In Vitro
12
The study demonstrated that Selank did not directly affect GABAergic gene expression in neuroblastoma cells but may enhance the effects of GABA and olanzapine on gene expression.

Key findings

  1. 01Selank showed an anxiolytic effect comparable to classical benzodiazepines.
  2. 02GABA and Selank influence gene expression related to GABAergic neurotransmission.
  3. 03Olanzapine also affects the expression of these genes in the studied cells.
0.3 mg/kg a dayintraperitoneally(rat)7 days100 μg/kgintraperitoneally(rat)20 days300 mg/kgi.v.(cat)not mentioned0.3 mg/kgintraperitoneally(rat)not mentioned100 μg/kgintraperitoneally(rat)not mentioned300 μg/kgnot mentioned(rat)not mentioned300 μg/kgintraperitoneally(mouse)5 days100 μg/kgintraperitoneal(mouse)not mentioned
PubMed
Safety

Safety & Handling

Research Gaps

No randomized controlled trials have been conducted to assess the long-term effects of Selank in human populations. Additionally, the precise mechanisms through which Selank exerts its anxiolytic and cognitive-enhancing effects, particularly in relation to BDNF modulation and its interaction with other neurochemical pathways, remain unclear.

Solubility

Selank is soluble in water and saline solutions.

Storage & Handling

Lyophilized

Stable for 2+ years at -20°C, 12 months at 4°C

Reconstituted

Use within 14 days when refrigerated at 4°C

Avoid

Avoid repeated freeze-thaw cycles, direct light

Solvent

Bacteriostatic water or sterile saline recommended

Safety information is derived from published research and may not reflect all known risks. This is not medical advice.

Legal Status

Legal Status

🇩🇪DE

Not approved as a medicinal product. Not a controlled substance. Sale as research chemical is a legal grey area.

🇺🇸US

Not approved by the FDA. Not scheduled by the DEA.

🇦🇺AU

Not listed in the TGA schedules.

🇬🇧UK

Not approved as a medicinal product by the MHRA.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

Community Insights

Community Insights

Publications per Year

48 total
2
01
2
02
2
03
3
05
3
06
1
07
6
08
1
09
1
10
2
11
1
13
3
14
1
15
3
16
7
17
1
18
3
19
3
20
1
21
1
22
1
26
Pricing

Price Comparison

  • BESTSunrise BioresearchUS
    10mg
    $16.19
    Price/mg
    $1.62/mg
  • PeptiLab USAUS
    10mg
    $20.99
    Price/mg
    $2.10/mg
  • Alpha PeptidesUS
    10mg
    $24.16
    $21.74
    Price/mg
    $2.42$2.18/mg
    View10% · PEPSTACK10
  • Nextech LabsUS
    10mg
    $24.75
    Price/mg
    $2.48/mg
  • Orbitrex PeptideUS
    30mg
    $79.99
    Price/mg
    $2.67/mg

Top 5 of 61 offers from 55 vendors. Prices updated daily.

See all Selank prices
Mechanism

Tools

Mechanism

Related Peptides

Track Selank in PepStack

Log your research cycles, set reminders and visualize serum levels.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer